Please ensure Javascript is enabled for purposes ofwebsite accessibility
The National Desk dark theme brand iconThe National Desk light theme brand icon
Close Alert

Nonprofit drugmaker will soon sell insulin for $30 a vial, regardless of insurance

by EMILY BAUCUM, WOAI/KABB STAFF

UserWay icon for accessibility widget
This photo provided by Novo Nordisk Inc. shows its Tresiba brand insulin. (Novo Nordisk Inc. via AP)
This photo provided by Novo Nordisk Inc. shows its Tresiba brand insulin. (Novo Nordisk Inc. via AP)
Facebook Share IconTwitter Share IconEmail Share Icon
Loading ...